Clinical Trials Sponsored by French Intergroup of Myeloproliferative syndromes

Total 3 results

French Innovative Leukemia Organisation
French Intergroup of Myeloproliferative syndromes

Completed

COVID-19 Epidemic and Patients With Myeloproliferative Neoplasias (COVIM)

Myeloproliferative Neoplasm | COVID-19 Infection

France
Nantes University Hospital
French Intergroup of Myeloproliferative syndromes

Recruiting

SYTHROM Cohort, Myeloproliferative Neoplasia With Normal CBC and Thrombotic Complications (SYTHROM)

Thrombotic Patients | Diagnosis of Myeloproliferative Neoplasia | Impact of Treatment With Cytoreducing Agent

France
French Innovative Leukemia Organisation
Acute Leukemia French Association; French Intergroup of Myeloproliferative...

Recruiting

Evaluation of CPX-351 Monotherapy in Acute Myeloid Leukemia Secondary to Myeloproliferative Neoplasm (CPX-351 TA-SMP)

Acute Myeloid Leukemia | Myeloproliferative Syndrome

France

3

Subscribe